Anrate  Biopharmaceutical, China 

Anrate Biopharmaceutical was founded in August 2014. At present, the company produces more than 100 tons of recombinant human albumin raw material per year, equivalent to approximately 10 million bottles at 10 g per bottle. The company mitigates contamination risks associated with viruses and foreign substances in human blood, enabling large-scale production that is independent of plasma-derived sources.